Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Immuneering Corp Director's Dealing 2024

Mar 12, 2024

32973_dirs_2024-03-12_9c10d5a2-2e9c-4d20-b367-e0b55ca20632.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2024-03-11

Reporting Person: Schall Thomas J. (N/A)

More from Immuneering Corp

Interim / Quarterly Report 2026
May 15
Regulatory Filings 2026
May 15
Director's Dealing 2026
Feb 5
Director's Dealing 2026
Feb 5
Director's Dealing 2026
Feb 5
Director's Dealing 2026
Feb 5
Director's Dealing 2026
Feb 5
Director's Dealing 2026
Feb 5
Director's Dealing 2026
Feb 5
Major Shareholding Notification 2026
Jan 22
View all filings →